Biovail Corp. has made changes to its business infrastructure, reorganizing itself into three distinct business units: Biovail Drug Delivery (BDD), which comprises Biovail’s drug-delivery technologies, its drug-development capabilities and its strategic partnerships; Biovail Pharmaceuticals U.S. (BPUS), which focuses on the promotion of products to specialists in niche therapeutic markets; and Biovail Pharmaceuticals Canada (BPC), which promotes products to both to specialist and primary-c...